Patents by Inventor Susan Snape

Susan Snape has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL ADMINISTRATION TO NEONATES, INFANTS AND CHILDREN
    Publication number: 20220008666
    Abstract: The invention provides methods, devices and compositions for use in inhalation therapy of neonates, infants or children younger than 12 years, e.g. from 1 to 8 years, suffering from a disease, optionally a pulmonary disease, such as asthma, by which high amounts of inhaled drugs are directed to the small airways of the peripheral lungs of neonates, infants and children using slow, controlled flow rates and pre-set inhalation volumes.
    Type: Application
    Filed: October 16, 2019
    Publication date: January 13, 2022
    Inventors: Bernhard MUELLINGER, Susan SNAPE
  • Use of glycopyrrolate for treating tachycardia
    Patent number: 10695321
    Abstract: The invention relates to a novel use of the antimuscarinic agent glycopyrrolate, for example the salt glycopyrronium bromide. In particular, the invention relates to glycopyrrolate for use as a heart rate lowering agent and more particularly, but not exclusively, for use in patients suffering from respiratory conditions such as chronic obstructive pulmonary disease.
    Type: Grant
    Filed: January 31, 2016
    Date of Patent: June 30, 2020
    Assignee: HEPTARES THERAPEUTICS LIMITED
    Inventors: Susan Snape, Robert Tansley
  • Use of Glycopyrrolate for Treating Tachycardia
    Publication number: 20160143880
    Abstract: The invention relates to a novel use of the antimuscarinic agent glycopyrrolate, for example the salt glycopyrronium bromide. In particular, the invention relates to glycopyrrolate for use as a heart rate lowering agent and more particularly, but not exclusively, for use in patients suffering from respiratory conditions such as chronic obstructive pulmonary disease.
    Type: Application
    Filed: January 31, 2016
    Publication date: May 26, 2016
    Inventors: Susan SNAPE, Robert TANSLEY
  • USE OF GLYCOPYRROLATE FOR TREATING TACHYCARDIA
    Publication number: 20140080890
    Abstract: The invention relates to a novel use of the antimuscarinic agent glycopyrrolate, for example the salt glycopyrronium bromide. In particular, the invention relates to glycopyrrolate for use as a heart rate lowering agent and more particularly, but not exclusively, for use in patients suffering from respiratory conditions such as chronic obstructive pulmonary disease.
    Type: Application
    Filed: March 5, 2012
    Publication date: March 20, 2014
    Applicant: SOSEI R&D LTD
    Inventors: Susan Snape, Robert Tansley
  • Treatment of Respiratory Disease
    Publication number: 20080020048
    Abstract: Glycopyrrate or an analogue thereof is useful for the treatment of bronchospasm or as a rescue medication.
    Type: Application
    Filed: May 10, 2005
    Publication date: January 24, 2008
    Inventors: Susan Snape, Robin Bannister
  • Treatment of Childhood Asthma
    Publication number: 20070243260
    Abstract: Glycopyrrolate or an analogue thereof is useful for the treatment of childhood asthma.
    Type: Application
    Filed: May 10, 2005
    Publication date: October 18, 2007
    Inventors: Susan Snape, Robin Bannister